Bacterial ubiquinone biosynthesis enzymes (Ubi enzymes)

Bacterial ubiquinone biosynthesis enzymes represent a critical metabolic pathway responsible for the production of ubiquinone (Coenzyme Q), a vital lipid-soluble electron carrier in the aerobic respiratory chain. This pathway involves a series of enzymes, including UbiA (prenyltransferase), UbiD/UbiX (decarboxylases), and various hydroxylases and methyltransferases (UbiG, UbiH, UbiF), which convert chorismate into ubiquinone. Because ubiquinone is essential for ATP generation and maintaining redox balance in many pathogenic bacteria, these enzymes are considered promising targets for the development of novel narrow-spectrum or broad-spectrum antibiotics. Targeting this pathway is particularly attractive because several bacterial Ubi enzymes differ significantly in structure and mechanism from their eukaryotic counterparts, potentially allowing for selective toxicity. Inhibition of these enzymes leads to the disruption of cellular respiration, oxidative stress, and bacterial growth arrest. Current research focuses on identifying potent small-molecule inhibitors of UbiA and UbiX to combat multi-drug resistant infections.

Other names

Ubiquinone biosynthetic pathwayCoenzyme Q biosynthesis enzymesUbi protein complexBacterial CoQ biosynthesis

Inhibition of specific enzymes within the ubiquinone biosynthetic pathway (e.g., UbiA, UbiD, UbiX) disrupts the production of Coenzyme Q, leading to the collapse of the bacterial electron transport chain, loss of ATP production, and eventual cell death.